Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
Publication
, Conference
Demarest, JF
Published in: Retrovirology
December 2005
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Retrovirology
DOI
EISSN
1742-4690
Publication Date
December 2005
Volume
2
Issue
S1
Publisher
Springer Science and Business Media LLC
Related Subject Headings
- Virology
- 3107 Microbiology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Demarest, J. F. (2005). Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5. In Retrovirology (Vol. 2). Springer Science and Business Media LLC. https://doi.org/10.1186/1742-4690-2-s1-s13
Demarest, James F. “Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5.” In Retrovirology, Vol. 2. Springer Science and Business Media LLC, 2005. https://doi.org/10.1186/1742-4690-2-s1-s13.
Demarest JF. Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5. In: Retrovirology. Springer Science and Business Media LLC; 2005.
Demarest, James F. “Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5.” Retrovirology, vol. 2, no. S1, Springer Science and Business Media LLC, 2005. Crossref, doi:10.1186/1742-4690-2-s1-s13.
Demarest JF. Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5. Retrovirology. Springer Science and Business Media LLC; 2005.
Published In
Retrovirology
DOI
EISSN
1742-4690
Publication Date
December 2005
Volume
2
Issue
S1
Publisher
Springer Science and Business Media LLC
Related Subject Headings
- Virology
- 3107 Microbiology
- 1103 Clinical Sciences